Sylvia A. Holden
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer therapeutics and mechanisms, Cancer-related Molecular Pathways, Cancer, Lipids, and Metabolism, Cancer Research and Treatments
Most-Cited Works
- → Differentiation and reversal of malignant changes in colon cancer through PPARγ(1998)970 cited
- Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.(1998)
- → Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo(1990)316 cited
- Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).(1987)
- → Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents(1994)233 cited
- Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.(1990)
- Preclinical studies and clinical correlation of the effect of alkylating dose.(1988)
- Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.(2000)
- A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.(1993)
- → Influence of an anti‐angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy(1995)121 cited